ABSTRACT
PURPOSE: To document a case of phakomatous choristoma (PC), a rare benign periocular tumor, and to review the literature on previously reported cases. METHODS: The authors describe a case of PC and its clinical, histopathological, immunohistochemical, and radiological features, and present findings from a comprehensive review of all previously reported cases of this rare pediatric tumor. RESULTS: This case report and review highlights the benign clinical nature of PC. It typically presents at birth as a lower eyelid mass involving the orbit. Definitive diagnosis is made with hematoxylin and eosin stain showing the tumor's histological similarities to lenticular tissue. CONCLUSION: PC remains a rare entity that should be included in the differential of pediatric eyelid lesions. Surgical excision is curative, and the postoperative clinical course is unremarkable as there have been no reports of recurrence. Prompt recognition and surgical intervention may be warranted due to astigmatism and anisometropia induced by mass effect.
Subject(s)
Choristoma , Eyelid Diseases , Lens, Crystalline , Child , Choristoma/diagnosis , Eyelid Diseases/surgery , Eyelids/pathology , Humans , Infant, Newborn , Lens, Crystalline/pathology , Orbit/pathologyABSTRACT
Preseptal cellulitis and postseptal (orbital) cellulitis represent a spectrum of orbital infections which a primary care provider and ophthalmologist may see during practice. Most often these conditions occur through spread from the sinuses, though there are a variety of other inciting factors. These conditions can both present with erythema and edema, but a complete and thorough exam can help a practitioner differentiate the two. Patients should be treated with targeting the most common pathogens and followed very closely by their providers. This article will discuss the anatomy, pathogenesis, risk factors, diagnosis, management and prognosis of preseptal and orbital cellulitis.
Subject(s)
Abscess/therapy , Anti-Bacterial Agents/therapeutic use , Debridement , Drainage , Orbital Cellulitis/therapy , Staphylococcal Infections/therapy , Streptococcal Infections/therapy , Abscess/diagnosis , Aspergillosis/diagnosis , Aspergillosis/immunology , Aspergillosis/therapy , Cellulitis/diagnosis , Cellulitis/therapy , Haemophilus Infections/diagnosis , Haemophilus Infections/therapy , Humans , Immunocompromised Host/immunology , Mucormycosis/diagnosis , Mucormycosis/immunology , Mucormycosis/therapy , Orbital Cellulitis/diagnosis , Periosteum , Physicians, Primary Care , Primary Health Care , Severity of Illness Index , Staphylococcal Infections/diagnosis , Streptococcal Infections/diagnosis , Tomography, X-Ray ComputedABSTRACT
Patients with infection or inflammation of the eyelid will often first present to their primary care physicians with symptoms such as redness, swelling, tearing, itchiness, or a foreign body sensation. There are a variety of conditions that affect the eyelid which can cause such symptoms, and the exam and history can help a provider differentiate some of the more common conditions. This article will provide a comprehensive review of the background, diagnosis and management of dry eye disease, chalazion, hordeolum (stye), and preseptal cellulitis.
Subject(s)
Cellulitis/physiopathology , Chalazion/physiopathology , Dry Eye Syndromes/physiopathology , Hordeolum/physiopathology , Administration, Oral , Administration, Topical , Adrenal Cortex Hormones/therapeutic use , Anti-Bacterial Agents/therapeutic use , Cellulitis/diagnosis , Cellulitis/etiology , Cellulitis/therapy , Chalazion/diagnosis , Chalazion/therapy , Dry Eye Syndromes/diagnosis , Dry Eye Syndromes/therapy , Hordeolum/diagnosis , Hordeolum/therapy , Hot Temperature/therapeutic use , Humans , Meibomian Gland Dysfunction/diagnosis , Meibomian Gland Dysfunction/physiopathology , Meibomian Gland Dysfunction/therapy , Punctal Plugs , Sinusitis/complications , Xerophthalmia/diagnosis , Xerophthalmia/physiopathology , Xerophthalmia/therapyABSTRACT
Patients who experience trauma to the eyelid or the orbit may present to their primary care providers or directly to the emergency room for evaluation of their injuries. These patients will often be in pain and may have bleeding around the eye, which can make evaluation of these patients difficult. Many traumatic injuries to the eye require quick and immediate intervention. In this article, we will review the background, anatomy, exam and management of some of the most common eye traumas including eyelid lacerations, orbital hemorrhages, intraorbital foreign bodies, and orbital fractures.
Subject(s)
Eyelids/injuries , Facial Injuries/therapy , Foreign Bodies/therapy , Lacerations/therapy , Ophthalmologic Surgical Procedures , Orbital Fractures/therapy , Plastic Surgery Procedures , Retrobulbar Hemorrhage/therapy , Decompression, Surgical , Facial Injuries/diagnosis , Foreign Bodies/diagnosis , Hemorrhage/diagnosis , Hemorrhage/therapy , Humans , Lacerations/diagnosis , Orbit , Orbital Diseases/diagnosis , Orbital Diseases/therapy , Orbital Fractures/diagnosis , Physicians, Primary Care , Primary Health Care , Retrobulbar Hemorrhage/diagnosis , Suture Techniques , Tetanus/prevention & control , Tetanus Toxoid/therapeutic use , Therapeutic Irrigation , Tomography, X-Ray ComputedABSTRACT
BACKGROUND: Potentially Inappropriate Medication (PIM) use has been studied in a variety of older adult populations across the world. We sought to examine the prevalence and correlates of PIM use in older drivers. METHODS: We applied the American Geriatrics Society 2015 Beers Criteria to baseline data collected from the "brown-bag" review of medications for participants of the Longitudinal Research on Aging Drivers (LongROAD) study to examine the prevalence and correlates of PIM use in a geographically diverse, community-dwelling sample of older drivers (n = 2949). Proportions of participants who used one or more PIMs according to the American Geriatrics Society 2015 Beers Criteria, and estimated odds ratios (ORs) and 95% confidence intervals (CIs) of PIM use associated with participant characteristics were calculated. RESULTS: Overall, 18.5% of the older drivers studied used one or more PIM. The most commonly used therapeutic category of PIM was benzodiazepines (accounting for 16.6% of the total PIMs identified), followed by nonbenzodiazepine hypnotics (15.2%), antidepressants (15.2%), and first-generation antihistamines (10.5%). Compared to older drivers on four or fewer medications, the adjusted ORs of PIM use were 2.43 (95% CI 1.68-3.51) for those on 5-7 medications, 4.19 (95% CI 2.95-5.93) for those on 8-11 medications, and 8.01 (95% CI 5.71-11.23) for those on ≥12 medications. Older drivers who were female, white, or living in urban areas were at significantly heightened risk of PIM use. CONCLUSION: About one in five older drivers uses PIMs. Commonly used PIMs are medications known to impair driving ability and increase crash risk. Implementation of evidence-based interventions to reduce PIM use in older drivers may confer both health and safety benefits. TRIAL REGISTRATION: Not applicable.
